z-logo
open-access-imgOpen Access
High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread
Author(s) -
Hanna Odén Poulsen,
Anders Johansson,
Susanne Granholm,
Gunnar Kahlmeter,
Martin Sundqvist
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt159
Subject(s) - mecillinam , nitrofurantoin , escherichia coli , microbiology and biotechnology , biology , diversity (politics) , genetic diversity , enterobacteriaceae , genetics , medicine , gene , population , environmental health , sociology , anthropology
The empirical treatment with trimethoprim or ciprofloxacin of urinary tract infections (UTIs) is now questioned, partly due to the global expansion of a few resistant clonal groups of Escherichia coli.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom